PURA Anticipates Substantial Sales Acceleration From Projected Hemp-Derived CBD Market Expansion From To $22 Billion by 2022
December 04 2018 - 12:43PM
InvestorsHub NewsWire
Dallas, TX – December 4, 2018 –
InvestorsHub NewsWire -- Puration, Inc. (USOTC:
PURA) today released an update on its end of year sales drive
to reach or exceed $1 million in sales for 2018 and to add insight
into the 2019 anticipated sales
growth.
The company recently reported its revenue
for the nine months ending September 30,
2018 at $868,300 representing an increase of over
400% since the company reported $168,000 for the same
period last year. The company also realized a 50% profit margin
reporting a $448,800 bottom line for the nine months
ending September 30, 2018. Management believes the $1
million in annual sales benchmark is within reach for 2018 and
continues pushing to insure success. The company today
announced signing a new distributor, Savannah Distributing Company, opening up sales
of Puration’s EVERx CBD Sports Water for the first time within the
Southeast United States. Management anticipates additional
geographic distribution expansion announcements before the end of
the year.
Recent analyst coverage of Puration
included a $3 million estimated 2019 revenue projection.
Following the analyst coverage, Puraiton announced a $1
million agreement to produce a new private labeled CBD infused
bottled water for a health care industry firm. With what
appears to be the imminent legalization of hemp and hemp-derived
CBD in the United States under the 2018 Farm Act, demand for CBD
infused beverages could expand
rapidly.
“If the bill makes it through Congress and
is signed by President Trump, as widely expected, industrial hemp
should be legal on Jan. 1, 2019. If this occurs, the U.S. market
for hemp -- and its derivatives -- is expected to soar. The
hemp-derived CBD market is projected to rocket from about $591
million this year to $22 billion by 2022, according to the
Brightfield Group. That's a whopping 37-fold increase in just four
years!” (See Full
Article)
With Puration’s experience and expertise
in the production and sales of CBD infused beverages, combined with
the potential behind the legalization of hemp and hemp-derived CBD,
management anticipates the growth of private label CBD infused
beverages next year could be substantial. The company’s
existing $1 million private label agreement could just be the
beginning.
Puration has the sole license for beverage
production of U.S. Patent No. 9,199,960 entitled 'METHOD AND
APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE
CANNABIS PLANT'. The patent is owned by Puration partner
Kali, Inc. (USOTC: KALY) and Kali is currently working with
Puration in the formulation of multiple extract concentrates that
would enable Puration to produce a variety of private label CBD
beverages with different CBD
concentrates.
For more
information on Puration,
visit http://www.purationinc.com
Disclaimer/Safe
Harbor:
This news
release contains forward-looking statements within the meaning of
the Securities Litigation Reform Act. The statements reflect the
Company's current views with respect to future events that involve
risks and uncertainties. Among others, these risks include the
expectation that any of the companies mentioned herein will achieve
significant sales, the failure to meet schedule or performance
requirements of the companies' contracts, the companies' liquidity
position, the companies' ability to obtain new contracts, the
emergence of competitors with greater financial resources and the
impact of competitive pricing. In the light of these uncertainties,
the forward-looking events referred to in this release might not
occur. These statements have not been evaluated by the Food and
Drug Administration. These products are not intended to diagnose,
treat, cure, or prevent any
disease.
Puration,
Inc.
Contact:
Puration,
Inc.
Brian
Shibley,
info@aciconglomerated.com
(800)
861-1350
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Sep 2023 to Sep 2024